Electroducer mission is to improve current surgical treatments helping many patients as possible, particularly reducing complications during percutaneous cardiovascular interventions.
The company’s ambition is to develop medical devices integrating the minimalist approach to optimize percutaneous valves implantations (aortic, mitral, tricuspid) and complex coronary interventions allowing:
– Shortening procedures
– Reduction of radiation exposure
– Cost reduction
– Easy to operate for healthcare professionals
– More effective, more reliable and less invasive procedures
– Reduction of complication and convalescence time
Electroducer activities are guided by the challenging economic and regulatory context and by the founder’s vision focused on the patient and are supported by partnerships with internationally renowned experts, hospitals and industrial partners.